CLARIVATE PLC

8-K · clvt-20260605.htm iXBRL

0001764046 2026-06-05 2026-06-05

 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 8-K
 CURRENT REPORT
 Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 Date of Report (date of earliest event reported): June 5, 2026

 CLARIVATE PLC
 (Exact name of registrant as specified in its charter)

 Jersey , Channel Islands

 (State or other jurisdiction of incorporation or organization)

 001-38911

 (Commission File Number)

 N/A

 (I.R.S. Employer Identification No.)

 70 St. Mary Axe

 London

 EC3A 8BE

 United Kingdom

 (Address of Principal Executive Offices)

 ( 44 ) 207-433-4000
 Registrant's telephone number, including area code
 ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class

 Trading Symbol(s)

 Name of each exchange on which registered

 Ordinary Shares, no par value

 CLVT

 New York Stock Exchange

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 Emerging growth company  ☐
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
 complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
 Officers; Compensatory Arrangements of Certain Officers.
 Maroun S. Mourad, President, Intellectual Property of Clarivate Plc (the “Company”) will depart from his position, effective
 June 9, 2026. Following such date, Mr. Mourad will remain employed by the Company in a non-executive advisory role until
 September 30, 2026.
 In connection with the transition of his role, on June 6, 2026, the Company entered into a separation agreement with
 Mr. Mourad. Pursuant to the terms of the separation agreement, in exchange for his execution and non-revocation of a release
 of claims and continued compliance with the terms of his agreement (including his restrictive covenants), Mr. Mourad will
 receive (i) a cash payments equal to $450,000 representing a pro-rated target annual bonus for 2026, (ii) a lump sum payment
 representing reimbursement for the average monthly cost of COBRA for 18 months, and (iii) if applicable, a tax equalization
 payment to account for days of work in the United Kingdom.
 Pursuant to the terms of his existing arrangements, Mr. Mourad is subject to certain restrictive covenants, including 12-month
 post-termination non-compete and non-solicit obligations, a perpetual confidentiality obligation, a non-disparagement covenant
 and intellectual property assignment provisions.
 The foregoing description of the separation agreement with Mr. Mourad contained herein does not purport to be complete and is
 qualified in its entirety by reference to the complete text of his agreement, a copy of which will be filed as an exhibit to the
 Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
 Item 7.01 Regulation FD Disclosure.
 On June 8, 2026, the Company announced that Simon Webster will assume the role of President, Intellectual Property, effective
 as of June 10, 2026.
 The Company’s press release dated June 8, 2026 announcing the appointment of Simon Webster is attached hereto as Exhibit
 99.1.
 The information in this Item 7.01, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed”
 for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
 to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document
 pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.
 Item 9.01.  Financial Statements and Exhibits.
 (d) Exhibits.

 No.

 Description

 99.1

 Press release issued by Clarivate Plc dated June 8, 2026.

 104

 Cover page of this Current Report on Form 8-K formatted in Inline XBRL.

 SIGNATURE
 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
 its behalf by the undersigned hereunto duly authorized.

  

 CLARIVATE PLC

  

 Date: June 8, 2026

 By: /s/ John Doulamis

  

 Name:  John Doulamis

  

 Title:    Senior Vice President, General Counsel